Dr. Adeel Ajwad Butt | |
---|---|
Born | August 15, 1967 |
Nationality | American/Pakistani |
Alma mater |
|
Occupation | Physician-scientist |
Adeel Ajwad Butt is a Pakistani–American Infectious Diseases physician, Professor of Medicine and Population Health Sciences at the Weill-Cornell Medical College[1] He is also the founder President and CEO of Innovations in Healthcare Advocacy, Research and Training (I-HART).[2]
Butt obtained his MBBS from The Aga Khan University[3] and then moved to the U.S. to pursue his postgraduate studies. He completed his residency in Internal Medicine at the Mount Sinai School of Medicine affiliated hospitals in New York and then enrolled for fellowship training in Infectious Diseases at the LSU Health Sciences Center New Orleans in New Orleans. He also holds a Certificate in Clinical Research and a Master of Science degree in Clinical Effectiveness and Health Services Research from the University of Pittsburgh School of Medicine in 2006.[4]
He held the position of Chair of Medicine at Sheikh Khalifa Medical City, Abu Dhabi, UAE (SKMC).[5] Subsequently he was appointed as the first Chief Quality Officer(I) at Hamad Medical Corporation (HMC) and the inaugural Director of Hamad Healthcare Quality Institute in Qatar. Adeel Butt has provided advice and training to numerous governments, non-governmental organizations, and academic health systems across the globe. He is a member of the Board of Governors in National Institute of Health Pakistan and a member of several advisory committees at the Ministry of Public Health in Qatar. He serves on the Advisory Board of Infectious Diseases Society of America (IDSA) Global Health Taskforce and as Chair of International Advisory Panel for Electronic Health Record (EHR) implementation at the Aga Khan University over 4 countries.[6] He is also a life member of the Association of Physicians of Pakistani Descent of North America (APPNA), where he has been a pioneer of numerous programs and initiatives.[7]
Adeel Butt’s research focus has been hepatitis C virus(HCV) infection and HIV coinfection. He was also involved in National Institutes of Health sponsored AIDS Clinical Trials Network, where he was a member of the Viral Hepatitis Transformative Science Group and led several key clinical trials.[8] More recently his research focus has been on Emerging Infectious Diseases and antimicrobial resistance. in 2018 he led the care and investigation of MERS-CoV outbreaks in the UAE and served as a WHO consultant for this infection. He also led an initiative studying the evolving antimicrobial resistance in the UAE and its impact upon clinical outcomes. More recently, Adeel Butt has been actively involved in the COVID-19 pandemic response and COVID-19 research in Qatar and in the United States and has published more than 75 key papers on this topic.[9]
Butt has over 280 research papers in peer reviewed journals. He has an h-index of 75 and his work has been cited more than 21,000 times.[18] He also has more than 75 research papers on COVID to his credit including more than 10 publications in the New England Journal of Medicine and key papers in Annals of Internal Medicine, JAMA Int Med, Nature Medicine, Journal of Clinical Investigations, and many more.[19]